WHO Mad Money November 24, 2015
Nasdaq dropping 0. 5 . This morning we learned in a total blockbuster of a deal. That pfizer is trying to reinvent itself by buying allergan, agn, to be more efficient with overseas capital. Allergan gives them a way to do that. It cost them a pretty penny, the company is confident this is a good one. Allergan has an excellent vaccine and cancer franchises, including their benchmark drug, botox, which they havent raised the price up, while simultaneously keeping up with new uses for the darn thing, past wrinkles and migraines. Perhaps they can run into a new form of company with this merger th...